Lady Parts: Bruce E. Katz, MD, Ushers in Cosmetic Surgery’s Final Frontier
In the November PSP cover story, Bruce E. Katz, MD, talks about how he's helping to usher in cosmetic surgery's final frontier--vaginal rejuvenation.
Tag: FDA
All
PopularAll
Latest
FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
All
Latest
Survey Finds Americans Prioritizing Aesthetic Treatments Over Everyday Spending
More than half say they would give up takeout, dining out, or streaming services to afford non-surgical procedures, according to new consumer data.
Skinvive by Juvéderm Targets Neck Lines in New FDA Filing
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
Read More
FDA Approves Two New Hyaluronic Acid Fillers
One newly approved HA filler showed statistical superiority to Restylane-L at all measured time points over 12 months, while the other was superior at six and nine months despite 20% more Restylane-L being used.
Read More
Vivace Ultra Receives FDA Clearance
Aesthetics Biomedical’s Vivace Ultra microneedling RF device was cleared by the FDA for use in dermatological and surgical procedures.
Read More
UCLA Researchers Work On Lab Test to Detect Implant Ruptures
The UCLA researcher’s lab test would use blood and urine samples to provide a simpler and effective method for detecting implant ruptures.
Read More
FDA Approves Revance Daxxify for Frown Lines
Revance Therapeutics received FDA approval for Daxxify to be used as an injectable to improve moderate to severe frown lines in adults.
Read More
FDA Accepts Revance Resubmission for Frown Line Treatment
The FDA has accepted Revance’s BLA resubmission for DaxibotulinumtoxinA for Injection, designed to treat severe glabellar lines.
Read More
Allergan Celebrates 20 Years of Botox
Allergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Read More
Renuvion Maker Notified of Pending FDA Medical Device Safety Communication
Apyx Medical Corp.—developer of Helium Plasma Technology, which is marketed and sold as Renuvion® in the cosmetic surgery market —has been notified by the U.S. FDA that the agency intends to post a Medical Device Safety Communication related to the Apyx Medical’s Advanced Energy products.
Read More
Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Revance Therapeutics Inc, a biotechnology company focused on innovative aesthetic and therapeutic...
Read More
FDA Urges Companies to be ‘Recall Ready’
The U.S. FDA’s final guidance describes the steps companies should take, before a recall is necessary, to develop recall policies and procedures that include training, planning and record-keeping to reduce the time a recalled product is on the market.
Read More
FDA Advisory Panel Red Lights Integra’s Breast Reconstruction Mesh
An advisory panel on general and plastic surgery voted against recommending FDA approval of Integra LifeSciences’ SurgiMend mesh for the specific indication of breast reconstruction, even though the device has been used in breast reconstruction for more than a decade under a 510(k) clearance, MD+DI reports.
Read More
FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
The U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions, according to a news release.
Read More
FDA Approves Spatz3 Adjustable Gastric Balloon
The US Food and Drug Administration (FDA) has approved the Spatz3 Gastric Balloon, an adjustable gastric balloon system, to aid in weight loss for adult patients struggling with obesity, Spatz FGIA Inc announces in a news release.
Read More
ASDSA Applauds FDA for Safety Communication on Needle-less Injector Devices
The American Society for Dermatologic Surgery Association supports the U.S. Food and Drug Administration’s safety communication regarding needle-less devices, such as hyaluron pens (HA pens) for injection of dermal fillers.
Read More
R2 Technologies’ Glacial Rx System Earns Third FDA Indication and Unique Product Code
R2 Technologies Inc, a provider of CryoAesthetic medical devices, announces that its in-office system, Glacial Rx, is now FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal.
Read More